E
VentriPoint Diagnostics Ltd. VPT.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 22.50% 11.60% 3.34% 0.44% -6.61%
Total Depreciation and Amortization -7.22% -8.54% -9.20% -6.90% -6.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -0.97% 211.26% 118.53% 39.13% 24.40%
Change in Net Operating Assets 176.18% 44.77% 83.10% 51.87% 311.03%
Cash from Operations 55.44% 43.71% 27.10% 12.24% 6.01%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -27.61% 18.76% -- -- --
Total Debt Repaid 23.67% 22.92% 24.81% -53.91% -79.50%
Issuance of Common Stock 212.17% 3,113.30% 2,199.47% -- 999.64%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -91.91% -256.40% -- -- --
Cash from Financing 9.46% 128.71% 2,393.93% 2,204.22% 2,483.74%
Foreign Exchange rate Adjustments -2,133.33% 114.52% -- -415.60% -92.59%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 97.63% 97.74% 99.10% 68.40% 44.17%